期刊文献+

糖尿病对AMI患者PCI术后血小板对氯吡格雷反应性的影响 被引量:7

Effect of Diabetes Mellitus on Platelet Response to Clopidogrel in Patients with AMI after Percutaneous Coronary Intervention
下载PDF
导出
摘要 目的:了解糖尿病(DM)对急性心肌梗死(AMI)患者PCI术后血小板对氯吡格雷反应性的影响。方法:选择我院住院的AMI患者80例,其中急性ST段抬高型心肌梗死35例,非ST段抬高型心肌梗死45例。入院后均给予标准双联抗血小板治疗,7天后应用血栓弹力图仪测定二磷酸腺苷(ADP)诱导的血小板抑制率,抑制率低于20%定义为氯吡格雷反应不良,20%~50%为反应低下,大于50%为反应良好。根据是否合并DM,将患者分为DM组和非DM组,比较两组患者ADP诱导的血小板抑制率的差异。结果:80例AMI患者中合并DM患者28例,非DM患者52例,前者ADP诱导的血小板抑制率为(40.5±14.2)%,后者(61.7±21.6)%,两者差异用统计学意义(P<0.05)。合并DM的患者氯吡格雷反应不良比例高于非DM患者(28.6%v 19.2%),两组具有明显统计学差异(P<0.05)。结论:DM降低AMI患者血小板对氯吡格雷的反应性。 Objective: To understand the effect of diabetes mellitus(DM) on platelet response to clopidogrel in patients with acute myocardial infarction(AMI) after percutaneous coronary intervention(PCI).Methods: 80 patients with AMI were recruited,including 35 STEMI patients and 45 NSTEMI patients.The standard anti-platelet therapy,immediately 300mg aspirin and 600mg clopidogrel followed by 100mg aspirin and 75mg clopidogrel per day was offered after admission.Platelet inhibition rate induced by adenosine diphosphate(ADP) was tested by thrombelastogram after admission 7 days.Lower inhibition rate than 20% was defined as adverse platelet response to clopidogrel.Inhibition rate 20%~50% is low.Inhibition rate more than 50% is good.The patients were divided into diabetes group and non-diabetes group based on diabetes history.The adenosine diphosphate(ADP)-induced platelet inhibition rate was compared between two groups.Results: There were 28 patients in diabetes group and 52 patients in non-diabetes group.The ADP-induced platelet inhibition rate was respectively(40.5±14.2)% and(61.7±21.6)% in diabetic group and non-diabetic group.There was obviously difference between two groups(P&lt;0.05).The proportion of lower response to clopidogrel in patients with DM is larger than that of nondiabetic patients(28.6% v 19.2%),there was distinct significant change in two groups(P&lt;0.05).Conclusion: DM reduces the response of platelet to clopidogrel in patients with AMI after PCI.
出处 《中国医药导刊》 2013年第7期1128-1129,1131,共3页 Chinese Journal of Medicinal Guide
关键词 急性心肌梗死 糖尿病 血栓弹力图 血小板反应性 Acute myocardial infarction Diabetes mellitus Thrombelastogram Platelet response
  • 相关文献

参考文献11

  • 1Lev EI,Patel RT,Maresh KJ,et al.Aspirin and clopidogrel drug response inpatients undergoing percutaneous coronary intervention:the role of dual drugresistance[J].J Am Coll Cardiol,2006;47(1):27-33.
  • 2Geisler T,Anders N,Paterok M,et al.Platelet response to clopidogrel is attenuatedin diabetic patients undergoing coronary stent implantation [J].Diabetes Care,2007;30(2):372-374.
  • 3史春青.氯吡格雷对不稳定型心绞痛患者血液流变及血小板功能的影响分析[J].中国医药导刊,2012,14(11):1957-1958. 被引量:3
  • 4Wang L,Wang X,Chen F.Clopidogrel resistance is associated with long-termthrombotic events in patients implanted with drug-eluting stents.Drugs R D,2010;10(4):219-224.
  • 5Angiolillo DJ,Fernandez-Ortiz A,Bernardo E,et al.Variability in individualresponsiveness to clopidogrel:clinical implications,management,and futureperspectives[J].J Am Coll Cardiol ,2007;49(14):1505-1516.
  • 6Muller I,Besta F9 Schulz C,et al.Prevalence of clopidogrel nonrespondersamong patients with stable angina pectoris scheduled for elective coronary stentplacement[J].Thromb Haemost,2003;89(5):783-787.
  • 7任艺虹,盖鲁粤,杨庭树,王洪叶,王禹,邢攸红,林琳,刘春雪.改良血栓弹力图法和流式细胞测定技术对血小板活性抑制程度的比较研究[J].中华心血管病杂志,2007,35(4):366-367. 被引量:37
  • 8Ferreiro JL,AngioIillo DJ.Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome[J].Circulation,20.11;123(7):798-813.
  • 9Andre J,Scheen.Aspirin and clopidogrel resistance in patients with diabetesmellitus[J].Eur Heart J,2006;27(23):2900-2910.
  • 10邸春霞,华宁,林乐健,张闯,唐发宽.老年糖尿病患者CYP2C19基因多态性与氯吡格雷抵抗的相关性[J].中国心血管病研究,2012,10(12):884-887. 被引量:6

二级参考文献27

  • 1刘欣.心绞痛的诊断及危险评估新进展[J].中国冶金工业医学杂志,2007,24(1):30-32. 被引量:2
  • 2高润霖,吴宁,胡大一,等.心血管病治疗指南和建议[M].北京:人民军医出版社,2005:158.
  • 3谈世进,杨建芬,李胜前.氯吡格雷联合阿司匹林对老年不稳定型心绞痛患者血小板活化的临床干预研究[J].实用老年医学,2007,21(4):243-245. 被引量:5
  • 4戴倩,王俊.不稳定型心绞痛治疗进展[J].疑难病杂志,2007,6(8):505-508. 被引量:65
  • 5Geiger J, Brich J, Honig-Lied P, et al. Specific impairment of human platelet P2YAC ADP receptor-mediated signaling by the antiplatelet drug clopidogrel. Arterioseler Thromb Vasc Biol, 1999,19 : 2007-2011.
  • 6Savi P, Herbert JM. Clopidogrel and ticlopidine: P2Y12 adeno- sine diphosphate-receptor antagonists for the prevention of atherothrombosis. Semin Thromb Hemost, 2005,31 : 174-183.
  • 7Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopi- dogrel. CMAJ,2009,180:713-718.
  • 8De Morals SM , Wilkinson GR, Blaisdell J, et al. The major ge- netic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem, 1994,269 : 15419-15422.
  • 9Giusti B, Gori AM, Marcucci R, et al. Relation of eytoehrome P450 2C19 loss-of-function polymorphism to oeeurrenee of drug- eluting coronary stent thrombosis. Am J Cardiol, 2009,103:806- 811.
  • 10糖尿病患者多重心血管危险因素综合管理中国专家共识组.《糖尿病患者多重心血管危险因素综合管理中国专家共识》出台.中国心血管病研究,2010,8:850.

共引文献43

同被引文献48

引证文献7

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部